The influence of surgical excision on survival in high-risk neuroblastoma revisited after introduction of ch14.18/CHO immunotherapy in the HR-NBL1/SIOPEN trial.

Keith Holmes,U. Poetschger,Sabine Sarnacki,Tom Monclair,Giovanni Cecchetto,Javier Gómez-Chacón,Jacob Stenman,Jean Marc Joseph,Roberto Luksch,Victoria Castel,Shifra Ash,Vassilios Papadakis,Josef Malis,Walentyna Balwierz,Cormac Owens,Holger N. Lode,Tom Boterberg,D. Couanet,Andrew D.J. Pearson,Ruth Ladenstein

The influence of surgical excision on survival in high-risk neuroblastoma revisited after introduction of ch14.18/CHO immunotherapy in the HR-NBL1/SIOPEN trial.

2018

10521Background: The effect of complete macroscopic excision (CME) of the primary tumour on event free survival (EFS) in high-risk neuroblastoma remains controversial. We therefore investigated the...

Keywords:

Neuroblastoma
Immunotherapy
Cancer research
Pathology
Medicine
event free survival
Oncology
Internal medicine
high risk neuroblastoma
surgical excision

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations